Septerna (SEPN) Interest & Investment Income (2023 - 2026)
Septerna (SEPN) recorded quarterly Interest & Investment Income of $5.0 million in Q1 2026, down 5.75% quarter-over-quarter from $5.3 million in Q4 2025, and up 12.75% on a YoY basis from $4.5 million in Q1 2025.
Septerna (SEPN) Interest & Investment Income (2023 - 2026) Analysis & Trends
Septerna's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 12.75% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $20.1 million (up 70.33% YoY), while the FY2025 annual figure was $19.5 million, up 126.65% from the prior year.
- Interest & Investment Income was $5.0 million for Q1 2026 at Septerna, down from $5.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $5.6 million in Q3 2025 to a low of $1.1 million in Q3 2023.
- Historically, Interest & Investment Income has averaged $3.2 million across 4 years, with a median of $3.9 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income soared 248.87% in 2025, then grew 12.75% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at $1.3 million in 2023, then jumped by 211.39% to $3.9 million in 2024, then soared by 36.59% to $5.3 million in 2025, then decreased by 5.75% to $5.0 million in 2026.
- The last three Interest & Investment Income figures came in at $5.0 million (Q1 2026), $5.3 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.03 Mn |
| Dec 31, 2025 | 5.34 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Jun 30, 2025 | 4.17 Mn |
| Mar 31, 2025 | 4.46 Mn |
| Dec 31, 2024 | 3.91 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.10 Mn |